Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Primary amine groups (-NH2) are fundamental chemical functional groups found at the N-terminus of polypeptide chains and on the side chains of lysine residues in proteins and various ligands. In the field of nanomedicine and drug delivery, these groups serve as essential reactive handles for the covalent attachment of targeting moieties or therapeutic proteins to synthetic polymers (Grabarek, Z., & Gergely, J., Analytical Biochemistry, 1990). The reaction with PLA-PEG-NHS involves a nucleophilic attack by the amine on the NHS ester, creating a stable amide linkage that functionalizes the surface of nanoparticles or micelles (Jokerst, J. V., et al., Nanomedicine, 2011). This bioconjugation strategy is widely employed to enhance the pharmacokinetics, stability, and tissue-specific targeting of drug delivery systems (Peer, D., et al., Nature Nanotechnology, 2007). While primary amines are critical for the structural and functional integrity of biomolecules, they are not therapeutic targets themselves; rather, they are chemical sites utilized for the engineering of advanced therapeutics. Consequently, the description provided refers to a chemical conjugation process rather than a biological receptor or enzyme target.
The primary amine group acts as a nucleophile that performs an acylation reaction on the N-hydroxysuccinimide (NHS) ester. This nucleophilic attack results in the displacement of the NHS leaving group and the formation of a stable, covalent amide bond between the polymer (PLA-PEG) and the ligand or protein (Hermanson, G. T., Bioconjugate Techniques, 2013).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Primary amine group (NH2).